Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003844priorityCriticalpatent/ECSP003844A/en
Publication of ECSP003844ApublicationCriticalpatent/ECSP003844A/en
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
239000003814drugSubstances0.000abstract1
229940079593drugDrugs0.000abstract1
238000000034methodMethods0.000abstract1
238000011321prophylaxisMethods0.000abstract1
238000011282treatmentMethods0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere al campo de la coagulación sanguínea. Se describen nuevos derivados de oxazolidinona de fórmula general (I) Procedimientos para su preparación así como su uso como principio activo en medicamentos para la profilaxis y/o tratamiento de enfermedades.The invention relates to the field of blood coagulation. New oxazolidinone derivatives of the general formula (I) are described. Procedures for their preparation as well as their use as an active ingredient in drugs for the prophylaxis and / or treatment of diseases.
ECSP0038442000-12-212000-12-21
SUBSTITUTED OXAZOLIDINONES AND ITS USE
ECSP003844A
(en)
compound, use of a compound, pharmaceutical composition, pharmaceutical aerosol formulation, and method for treating a human or animal patient with an anti-inflammatory and / or allergic condition